Koutsouras George W, Rahmani Redi, Schmidt Tyler, Silberstein Howard, Bhalla Tarun
1Department of Biomedical Sciences, New York Institute of Technology College of Osteopathic Medicine, Old Westbury; and.
2Department of Neurological Surgery, University of Rochester, New York.
J Neurosurg Pediatr. 2019 Jan 1;23(1):80-85. doi: 10.3171/2018.6.PEDS1819. Epub 2018 Oct 5.
Neonatal dural arteriovenous fistulas (DAVFs) are rare, but if left untreated will advance to life-threatening neurological and cardiovascular compromise. Endovascular treatment is the preferred treatment modality for DAVFs. The goal of endovascular therapy is to obliterate feeding vasculature and prevent secondary complications. Endovascular access can be difficult to obtain in a neonate. The authors present the case of a full-term, normal birth weight neonate with severe congestive heart failure secondary to a congenital DAVF of the torcular herophili that was successfully treated with transumbilical arterial coil embolization and a liquid embolic agent.
新生儿硬脑膜动静脉瘘(DAVFs)较为罕见,但如果不进行治疗,将会发展为危及生命的神经和心血管功能障碍。血管内治疗是DAVFs的首选治疗方式。血管内治疗的目标是闭塞供血血管并预防继发性并发症。在新生儿中获得血管内通路可能较为困难。作者报告了一例足月、出生体重正常的新生儿病例,该患儿因窦汇先天性DAVFs继发严重充血性心力衰竭,经脐动脉线圈栓塞和液体栓塞剂成功治疗。